Antioxidants and ischaemic heart disease
Violi, F.; Iuliano, L.; Iullano, L.
Lancet 350(9078): 667-668
1997
ISSN/ISBN: 0140-6736 PMID: 9288075 Document Number: 469637
Document emailed within 1 workday
Related Documents
Yarnell, J.W.; Limb, E.S.; Layzell, J.M.; Baker, I.A. 1992: Height: a risk marker for ischaemic heart disease: prospective results from the Caerphilly and Speedwell Heart Disease Studies European Heart Journal 13(12): 1602-1605Golan, D.T.; Kursbaum, A. 1976: Anti-heart autoantibodies in ischaemic heart disease patients Clinical and Experimental Immunology 26(1): 86-90
1997: Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group Lancet 349(9049): 375-380
Nony, P.; Boissel, J.P.; Girard, P.; Leizorovicz, A.; Lievre, M.; Chifflet, R. 1992: Relative efficacy of angiotensin converting enzyme inhibitors on mortality of patients with congestive heart failure: implications of randomized trials and role of the aetiology (ischaemic or non-ischaemic) of heart failure European Heart Journal 13(8): 1101-1108
Tsanova, V.; Shakhov, B. 1990: The use of antioxidants in treating ischemic heart disease Vutreshni Bolesti 29(5): 22-28
Bashir, R.; Khan, A.; Yousaf, M. 1996: Angiographically documented coronary artery disease in asymptomatic middle aged men suspected of silent ischaemic heart disease Jpma. Journal of the Pakistan Medical Association 46(10): 225-228
Christie, J. 2011: Ischaemic heart disease prevention NursingTimes 107(30-31): 20
Law, M.R.; Wald, N.J. 1999: Homocysteine and ischaemic heart disease Haematologica 84 Suppl Eha-4: 57-60
Wojtczak, A.; Skretkowicz, J. 2007: Genetics in ischaemic heart disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 23(133): 5-8
Van Assche, F.A.; Aerts, L.; Holemans, K. 1994: Low birthweight and ischaemic heart disease Lancet 343(8899): 731-732
Lhotka, J.; Stuchlíková, E.; Klimesová, A. 1971: Changes in the pericardium in ischaemic heart disease Acta Universitatis Carolinae. Medica 17(7): 573-580
Constantine, G.R.; Thenabadu, P.N. 1996: Use of aspirin in ischaemic heart disease Ceylon Medical Journal 41(4): 167-168
Rapola, J.M. 1998: Should we prescribe antioxidants to patients with coronary heart disease? European Heart Journal 19(4): 530-532
Galli, C.; Visioli, F. 2000: N-3 fatty acids and antioxidants in coronary heart disease Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 1(Suppl 3): S20-S21
Pavrovský, J.; Lichtenberg, J.; Vancura, J.; Vanousová, E.; Kucera, M.; Jezek, V. 1974: Vineberg's operation in ischaemic heart disease Sbornik Lekarsky 76(1): 8-14
Boyle, R.M. 1981: Exercise testing in ischaemic heart disease British Journal of Hospital Medicine 25(1): 8-14
Krishnaswami, S.; Cherian, G. 1980: Ischaemic heart disease nomenclature and definitions Journal of the Association of Physicians of India 28(8): 239-240
Hansen, G.M.ør.; Holmstrup, P.; Tolker-Nielsen, T.; Køllgaard, T.; Nielsen, C.H.; Givskov, M.; Hansen, P.R. 2014: A possible correlation between periodontitis and ischaemic heart disease Ugeskrift for Laeger 176(18)
Sabaté, J. 1993: Does nut consumption protect against ischaemic heart disease? European Journal of Clinical Nutrition 47(Suppl): S71-S75
Kornacewicz-Jach, Z.ła.; Kossuth, I.; Czechowska, M.łg. 2005: How to diagnose ischaemic heart disease in females? Kardiologia Polska 62(3): 294-298